Sixty senators today urged the Centers for Medicare & Medicaid Services to delay the April 21 release of the overall hospital quality star ratings in order “to provide the necessary time to more closely examine the star rating methodology, analyze its impact on different types of hospitals, and provide more transparent information regarding the calculation of the ratings to determine accuracy.” The senators wrote, “While we support the public reporting of provider quality data, we are concerned that the current Star Ratings system may not accurately take into account hospitals that treat patients with low socioeconomic status or multiple complex chronic conditions. We appreciate CMS’s recognition in previous rulemaking of the effects these patient populations have on Medicare Advantage and Part D plans and urge CMS to give similar consideration to the similar effects on the Hospital Compare Star Ratings system.” The letter was spearheaded by Sens. Rob Portman (R-OH) and Bob Casey (D-PA). Reps. Jim Renacci (R- OH) and Bill Pascrell (D-NJ) are collecting signatures through Wednesday for a similar letter in the House.

Related News Articles

Headline
The Joint Commission June 30 announced a new, streamlined process that removes 714 requirements from its hospital accreditation program. The new program,…
Headline
AHA President and CEO Rick Pollack explains how hospitals have made meaningful progress in patient safety and delivering high-quality care, in a column…
Headline
A 60-day appeal window has passed for the Food and Drug Administration to appeal a federal court ruling that invalidated its final rule to regulate laboratory-…
Headline
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump…
Headline
The AHA Living Learning Network is launching the Quality Exchange, a virtual collaborative for health care quality and patient safety professionals at…
Headline
The U.S. District Court for the Eastern District of Texas March 31 ruled that the Food and Drug Administration does not have the authority to regulate…